HARBIN, China--(BUSINESS WIRE)--Renhuang Pharmaceuticals, Inc. (or "the Company", Stock symbol: RHGP.OB), a leading provider of natural health care products in the People's Republic of China (PRC), today announced the approval by the Russian FDA of its Acanthopanax pill.
